RKIP downregulation induces the HBx-mediated Raf-1 mitochondrial translocation

Sun Young Kim1, Sung Goo Park, Hyeyun Jung

  • 1Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnlogy, Daejeon, Korea.

Insights

Raf-1 kinase inhibitory protein (RKIP) downregulation promotes liver cancer by increasing Raf-1 mitochondrial translocation, enhancing cell survival and tumor growth during HBx-mediated hepatocarcinogenesis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Hepatology

Background:

  • Raf-1 kinase inhibitory protein (RKIP) regulates key signaling pathways, including the Ras-Raf-1-MEK1/2-ERK1/2 pathway.
  • Raf-1 kinase can translocate to mitochondria, conferring protection against stress-induced apoptosis.
  • Hepatitis B virus X protein (HBx) promotes mitochondrial translocation of Raf-1, contributing to anti-apoptotic effects.

Purpose of the Study:

  • To investigate the role of RKIP in HBx-mediated hepatocarcinogenesis.
  • To elucidate the mechanism by which RKIP influences Raf-1 mitochondrial translocation and apoptosis.

Main Methods:

  • Investigated the interaction between RKIP and Raf-1.
  • Assessed the effect of RKIP on Raf-1 translocation to mitochondria.
  • Evaluated the impact of RKIP downregulation on apoptosis and hepatocarcinogenesis in an HBx model.

Main Results:

  • RKIP was found to be downregulated during HBx-mediated hepatocarcinogenesis.
  • RKIP directly binds to Raf-1, inhibiting its translocation into mitochondria.
  • Downregulation of RKIP leads to increased free Raf-1, promoting its mitochondrial translocation, enhancing anti-apoptotic effects, and consequently promoting hepatocarcinogenesis.

Conclusions:

  • RKIP plays a critical role in suppressing hepatocarcinogenesis by inhibiting Raf-1 mitochondrial translocation.
  • The downregulation of RKIP is a key event in HBx-mediated liver cancer development, promoting cell survival.
  • Targeting the RKIP-Raf-1 interaction could offer a therapeutic strategy for HBx-associated hepatocellular carcinoma.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...